cardiovascular risk的意思

cardiovascular risk中文翻譯：

心血管危險

相似詞語短語

cardiovascular disease───[內科]心血管疾病；冠心病

cardiovascular fitness───心血管適應能力

cardiovascular system───[解剖]心血管系統

cardiovascular───adj.[解剖]心血管的

cardiovascular conditioning───心血管調節

cardiac arrest───心搏停止

cerebrovascular accident───[內科]腦血管意外（等于中風）；腦血管傷害

avascularity───n.無血管

cardiac arrests───心跳停止；心搏停止

雙語使用場景

Step 1: Calculate your cardiovascular risk points.───一步：計算你的心血管風險分數。

Check and control your cardiovascular risk.───檢查并控制你的心血管疾病風險。

Physical exercise and reducing cardiovascular risk factors have the strongest evidence.───體育鍛煉和減少心血管疾病的危險因素對防止阿爾茨海默氏癥具有最強有力的證據。

Thus, gum infections seem to add to the inflammatory burden on individuals, increasing cardiovascular risk, the researchers say.───因此，牙齦感染似乎增加了個體的炎性負荷，增加了心血管疾病的發生危險。

For tea, the association between consumption and cerebral infarction also did not vary significantly by age or cardiovascular risk factors.───對茶來說，攝取量和腦梗塞之間的關聯同樣并沒有因年齡或心血管風險因素而改變。

The ADMA plasma level also tended to increase with an increasing number of classic cardiovascular risk factors, the researchers note.───研究者還注意到：ADMA血漿水平傾向于隨著傳統的心血管風險因子種類的增加而增加。

Individuals found to have prediabetes should be evaluated and treated, if appropriate, for other cardiovascular risk factors (B).───個人發現有糖尿病前期應當評價和處理，如果合適，應對其他心血管危險因素應當評價和處理（B）。

So just like anybody who has cardiovascular risk, low cholesterol and low saturated fat should be a major part of the diet.───如心血管高危患者一樣，食物應當低膽固醇和低飽和脂肪酸。

CONCLUSIONS Weight reduction with GLP-1 receptor agonists was associated with a shift toward a more favorable cardiovascular risk profile.───結論：GLP-1受體激動劑治療后的體重減輕與心血管危險因素譜向更有益的方向轉變有關。

英語使用場景

Probably mainly for patients with very high cardiovascular risk, for instance those patients with cardiovascular disease and with target organ damage.

ACCORD Lipid confirms both the hypothesis and the value of adding fenofibrate to a statin to reduce this high residual cardiovascular risk.

Objective To determine serum true insulin (TI) and proinsulin (PI) levels in patients with coronary heart disease (CHD), and to explore the relationships of them to other cardiovascular risk factors.

The goal of this statement was to develop evidence-based EULAR recommendations for cardiovascular risk management in patients with RA, ankylosing spondylitis, and psoriatic arthritis.

Cardiovascular risk needs to be taken into account when prescribing any non-steroidal anti-inflammatory drug.

Individuals found to have prediabetes should be evaluated and treated, if appropriate, for other cardiovascular risk factors (B).

The increased cardiovascular risk compared with placebo was reported in a 2004 analysis of the adenomatous polyp prevention on Vioxx (APPROVe) study, w13 which led to the drug's withdrawal.

The effect of cyclooxygenase-2 inhibitors and most nonsteroidal anti-inflammatory drugs (NSAIDs) on cardiovascular risk is not completely determined and should be studied further.

The current recommended diabetic dietary regimen appears to result in a reduction in lipid cardiovascular risk.